Cardio-Oncology Understanding the Intersections Between Cardiac Metabolism and Cancer Biology

An important priority in the cardiovascular care of oncology patients is to reduce morbidity and mortality, and improve the quality of life in cancer survivors through cross-disciplinary efforts. The rate of survival in cancer patients has improved dramatically over the past decades. Nonetheless, survivors may be more likely to die from cardiovascular disease in the long term, secondary, not only to the potential toxicity of cancer therapeutics, but also to the biology of cancer. In this context, efforts from basic and translational studies are crucial to understanding the molecular mechanisms causal to cardiovascular disease in cancer patients and survivors, and identifying new therapeutic targets that may prevent and treat both diseases. This review aims to highlight our current understanding of the metabolic interaction between cancer and the heart, including potential therapeutic targets. An overview of imaging techniques that can support both research studies and clinical management is also provided. Finally, this review highlights opportunities and challenges that are necessary to advance our understanding of metabolism in the context of cardio-oncology. (C) 2021 Published by Elsevier on behalf of the American College of Cardiology Foundation.

Automated summary

An important priority in cardiovascular care for oncology patients is to reduce morbidity and mortality, and improve the quality of life in cancer survivors. Basic and translational research efforts are crucial for understanding the molecular mechanisms of cardiovascular diseases in cancer patients and survivors, and for identifying new therapeutic targets. Understanding the metabolic interaction between cancer and the heart, along with providing imaging techniques to support research studies and clinical management, are essential for advancing our understanding of metabolism in cardio-oncology.